Stratos Wealth Partners LTD. Reduces Stock Holdings in The Clorox Company (NYSE:CLX)

Stratos Wealth Partners LTD. reduced its stake in shares of The Clorox Company (NYSE:CLX) by 8.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,155 shares of the company’s stock after selling 657 shares during the period. Stratos Wealth Partners LTD.’s holdings in Clorox were worth $1,162,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the company. Catalyst Capital Advisors LLC acquired a new stake in Clorox in the 3rd quarter valued at $54,000. Los Angeles Capital Management LLC grew its position in shares of Clorox by 5.6% in the third quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock valued at $31,266,000 after purchasing an additional 10,149 shares in the last quarter. Advisors Asset Management Inc. increased its stake in shares of Clorox by 43.4% in the 3rd quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company’s stock worth $4,865,000 after acquiring an additional 9,037 shares during the last quarter. Natixis Advisors LLC boosted its holdings in Clorox by 8.3% in the 3rd quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock valued at $10,341,000 after purchasing an additional 4,839 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in Clorox by 1.8% in the third quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock worth $117,932,000 after acquiring an additional 13,038 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

Clorox stock opened at $148.51 on Monday. The stock has a fifty day moving average price of $161.06 and a 200 day moving average price of $158.88. The company has a current ratio of 0.94, a quick ratio of 0.62 and a debt-to-equity ratio of 20.52. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The firm has a market capitalization of $18.38 billion, a P/E ratio of 40.58, a PEG ratio of 2.52 and a beta of 0.42.

Clorox (NYSE:CLX) last released its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period last year, the company earned $2.16 earnings per share. Equities research analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 3.29%. Clorox’s dividend payout ratio is currently 133.33%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the stock. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and upped their price objective for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. Evercore ISI increased their price objective on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. DA Davidson reduced their price target on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Finally, Barclays lifted their price objective on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research note on Wednesday, February 5th. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $158.21.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.